cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Urogen Pharma Ltd
3 watching
Current Price
$9.27
$-1.75
(-15.88%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
213.31M
52-Week High
52-Week High
12.6317
52-Week Low
52-Week Low
4.85
Average Volume
Average Volume
0.14M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization213.31M
icon52-Week High12.6317
icon52-Week Low4.85
iconAverage Volume0.14M
iconDividend Yield--
iconP/E Ratio--
What does the Urogen Pharma Ltd do?
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company s lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial carcinoma and low-grade non-muscle invasive bladder cancer. It is also developing UGN-301 for the treatment of high-grade non-muscle invasive bladder cancer. The company has a license agreement with Allergan Pharmaceuticals International Limited for developing and commercializing pharmaceutical products that contain RTGel and clostridial toxins; Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; and strategic research collaboration with MD Anderson to advance investigational treatment for high-grade bladder cancer. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey.
Read More
How much money does Urogen Pharma Ltd make?
News & Events about Urogen Pharma Ltd.
Business Wire
25days ago
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today highlights results from the first and largest post-commercial utilization review of JELMYTO (mitomycin) for pyelocalyceal...
Business Wire
1month ago
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, announced that the Phase 3 ENVISION study of investigational agent UGN-102 (mitomycin) for intravesical solution in development for the...
Business Wire
1month ago
UroGen Pharma Ltd. (Nasdaq: URGN) a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units (RSUs) to 12 new employees in connection with their employment with...
Business Wire
2 months ago
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced new data from the OPTIMA II study designed to obtain long-term follow-up data on UGN-102 that shows median duration of...
Business Wire
2 months ago
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced financial results for the third quarter ended September 30, 2022, and provided an overview of recent developments. From...
Frequently Asked Questions
Frequently Asked Questions
What is Urogen Pharma Ltd share price today?
plus_minus_icon
Can Indians buy Urogen Pharma Ltd shares?
plus_minus_icon
How can I buy Urogen Pharma Ltd shares from India?
plus_minus_icon
Can Fractional shares of Urogen Pharma Ltd be purchased?
plus_minus_icon
What are the documents required to start investing in Urogen Pharma Ltd stocks?
plus_minus_icon
What is today’s traded volume of Urogen Pharma Ltd?
plus_minus_icon
What is today’s market capitalisation of Urogen Pharma Ltd?
plus_minus_icon
What is the 52-Week High and Low Range of Urogen Pharma Ltd?
plus_minus_icon
What percentage is Urogen Pharma Ltd down from its 52-Week High?
plus_minus_icon
What percentage is Urogen Pharma Ltd up from its 52-Week Low?
plus_minus_icon
Current Price
$9.27
$-1.75
(-15.88%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00